AKTX

Akari Therapeutics

11 hedge funds and large institutions have $3.97M invested in Akari Therapeutics in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$883K

Top Sellers

1 -$2.96M
2 -$1.85M
3 -$1.29M
4
DM
Deerfield Management
New York
-$1.08M
5
BBA
Baker Bros. Advisors
New York
-$649K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.16M
2
$823K
3
$629K
4
$618K
5
$359K
6
$311K
7
$55K
8
$14K
9
$4K
10
11
12
13
14
15
16
17
18